RecruitingNCT06054451

Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India


Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Enrollment

210 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

There is a need to re-evaluate the patients classified as NCPH and determine whether the new histological classification proposed by the VALDIG applies to the Indian scenario. We intend to identify the patient cohorts who have been diagnosed as NCPH, NCPF, EHPVO, hepatic venous outlet tract obstruction (HVOTO), Veno-occlusive disease (VOD) and sinusoidal obstruction syndrome (SOS) based on their liver biopsy, endoscopy, HVPG, and radiology reports. These patients will be screened to find the patients who fit the diagnosis of PSVD. It is important to establish whether the new definition of PSVD is relevant to the Indian population and establish the usefulness of invasive tests like liver biopsy in diagnosing the disease. The patient cohorts meeting diagnosis of INCPH will be compared with those meeting the new diagnosis of PSVD. The investigators will describe the clinical (demographic, clinical risk factors, socioeconomic status), etiological (associated conditions, coagulation disorders medication use, genetic risk factors), imaging (based on ultrasound Doppler imaging or cross- sectional imaging), endoscopic, fibrosis tests (using non-invasive tests), and the histopathology of the patients who fulfil the criteria of PSVD.


Eligibility

Min Age: 12 YearsMax Age: 70 Years

Inclusion Criteria1

  • Patients of 12-70 years, either gender with clinical, pathological radiological diagnosis of NCPH

Exclusion Criteria2

  • Any patients having Cirrhosis based on clinical, pathological, or radiological diagnosis
  • Any patients having active malignancy

Locations(1)

Dr. Madhumita Premkumar

Sector-12, Chandigarh, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06054451


Related Trials